Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Dooley, J.M.
Camfield, P.R.
Smith, E.
Langevin, P.
and
Ronen, G.
1999.
Topiramate in Intractable Childhood Onset Epilepsy - A Cautionary Note.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques,
Vol. 26,
Issue. 4,
p.
271.
Harvey, Brian H.
and
Bouwer, Colin D.
2000.
Neuropharmacology of Paradoxic Weight Gain with Selective Serotonin Reuptake Inhibitors.
Clinical Neuropharmacology,
Vol. 23,
Issue. 2,
p.
90.
2000.
Letters to the Editor.
The Canadian Journal of Psychiatry,
Vol. 45,
Issue. 5,
p.
489.
Ueberall, Michael A
2001.
Normal growth during lamotrigine monotherapy in pediatric epilepsy patients — a prospective evaluation of 103 children and adolescents.
Epilepsy Research,
Vol. 46,
Issue. 1,
p.
63.
Kopec, Kelly
2001.
New anticonvulsants for use in pediatric patients (part I).
Journal of Pediatric Health Care,
Vol. 15,
Issue. 2,
p.
81.
Theisen, F.
Linden, A.
Sommerlad, C.
Krieg, J.-C.
Remschmidt, H.
and
Hebebrand, J.
2001.
Leponex.
p.
103.
Smith, Amanda G
Brauer, Heidi R
Catalano, Glenn
and
Catalano, Maria C
2001.
Topiramate Overdose: A Case Report and Literature Review.
Epilepsy & Behavior,
Vol. 2,
Issue. 6,
p.
603.
Krymchantowski, Abouch V.
Bigal, Marcelo E.
and
Moreira, Pedro F.
2002.
New and Emerging Prophylactic Agents for Migraine.
CNS Drugs,
Vol. 16,
Issue. 9,
p.
611.
Biton, Victor
Levisohn, Paul
Hoyler, Sheri
Vuong, Alain
and
Hammer, Anne E.
2003.
Lamotrigine Versus Valproate Monotherapy—Associated Weight Change in Adolescents With Epilepsy: Results From a Post Hoc Analysis of a Randomized, Double-Blind Clinical Trial.
Journal of Child Neurology,
Vol. 18,
Issue. 2,
p.
133.
Lee, Suzee
Sziklas, Viviane
Andermann, Frederick
Farnham, Sara
Risse, Gail
Gustafson, Mary
Gates, John
Penovich, Patricia
Al‐Asmi, Abdullah
Dubeau, Francois
and
Jones‐Gotman, Marilyn
2003.
The Effects of Adjunctive Topiramate on Cognitive Function in Patients with Epilepsy.
Epilepsia,
Vol. 44,
Issue. 3,
p.
339.
Traub, Stephen J.
Ann Howland, Mary
Hoffman, Robert S.
and
Nelson, Lewis S.
2003.
Acute Topiramate Toxicity.
Journal of Toxicology: Clinical Toxicology,
Vol. 41,
Issue. 7,
p.
987.
Chung, Allison M
and
Reed, Michael D
2004.
Intentional Topiramate Ingestion in an Adolescent Female.
Annals of Pharmacotherapy,
Vol. 38,
Issue. 9,
p.
1439.
Bigal, Marcelo E.
Krymchantowski, Abouch V.
and
Rapoport, Alan M.
2004.
Prophylactic migraine therapy: Emerging treatment options.
Current Pain and Headache Reports,
Vol. 8,
Issue. 3,
p.
178.
Marsden, Dorothy
and
Libretto, Susan E
2004.
Hypersensitivity to Topiramate Sprinkle Capsules Does not Preclude the Use of Topiramate Tablets.
Pediatric Drugs,
Vol. 6,
Issue. 2,
p.
133.
Dunner, David L
2005.
Safety and tolerability of emerging pharmacological treatments for bipolar disorder.
Bipolar Disorders,
Vol. 7,
Issue. 4,
p.
307.
Silberstein, Stephen D.
2005.
Topiramate in Migraine Prevention.
Headache: The Journal of Head and Face Pain,
Vol. 45,
Issue. s1,
ROWBOTHAM, MICHAEL C.
2005.
Peripheral Neuropathy.
p.
2637.
Lin, George
and
Lawrence, Ruth
2006.
Pediatric Case Report of Topiramate Toxicity.
Clinical Toxicology,
Vol. 44,
Issue. 1,
p.
67.
Okuyucu, E.
Melek, İ. M.
Duman, T.
and
Tunç, T.
2007.
Hypomania complicating topiramate therapy for migraine prophylaxis.
European Journal of Neurology,
Vol. 14,
Issue. 3,
Chung, Steve
Wang, Norman
and
Hank, Nicole
2007.
Comparative retention rates and long-term tolerability of new antiepileptic drugs.
Seizure,
Vol. 16,
Issue. 4,
p.
296.